Literature DB >> 16838037

Hepatocyte growth factor: new arsenal in the fights against renal fibrosis?

Y Liu1, J Yang.   

Abstract

Hepatocyte growth factor (HGF) has emerged as a potent, endogenous antifibrotic factor that shows an impressive efficacy in ameliorating tissue fibrosis in a wide variety of animal models. Herrero-Fresneda et al. provide new evidence demonstrating that intramuscular injection of HGF gene reduces mortality, inflammation, and renal fibrosis in chronic allograft nephropathy.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16838037     DOI： 10.1038/sj.ki.5001661

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  18 in total

1.  An overview of the c-MET signaling pathway.

Authors:  Shawna Leslie Organ; Ming-Sound Tsao
Journal:  Ther Adv Med Oncol       Date:  2011-11       Impact factor: 8.168

2.  Urinary biomarkers and renal recovery in critically ill patients with renal support.

Authors:  Nattachai Srisawat; Xiaoyan Wen; Minjae Lee; Lan Kong; Michele Elder; Melinda Carter; Mark Unruh; Kevin Finkel; Anitha Vijayan; Mohan Ramkumar; Emil Paganini; Kai Singbartl; Paul M Palevsky; John A Kellum
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-14       Impact factor: 8.237

Review 3.  Renal interstitial fibrosis: mechanisms and evaluation.

Authors:  Alton B Farris; Robert B Colvin
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-05       Impact factor: 2.894

4.  Future directions in the evaluation of c-MET-driven malignancies.

Authors:  Johann S de Bono; Timothy A Yap
Journal:  Ther Adv Med Oncol       Date:  2011-11       Impact factor: 8.168

Review 5.  The role of cell plasticity in progression and reversal of renal fibrosis.

Authors:  Jean-Claude Dussaule; Dominique Guerrot; Anne-Cécile Huby; Christos Chadjichristos; Nasim Shweke; Jean-Jacques Boffa; Christos Chatziantoniou
Journal:  Int J Exp Pathol       Date:  2011-02-12       Impact factor: 1.925

6.  Morphometric and visual evaluation of fibrosis in renal biopsies.

Authors:  Alton B Farris; Catherine D Adams; Nicole Brousaides; Patricia A Della Pelle; A Bernard Collins; Ellie Moradi; R Neal Smith; Paul C Grimm; Robert B Colvin
Journal:  J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 10.121

Review 7.  Renal toxicity of targeted therapies.

Authors:  Ronan J Kelly; Bertrand Billemont; Olivier Rixe
Journal:  Target Oncol       Date:  2009-05-06       Impact factor: 4.493

8.  Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells.

Authors:  Takaharu Ichimura; Edwin J P V Asseldonk; Benjamin D Humphreys; Lakshman Gunaratnam; Jeremy S Duffield; Joseph V Bonventre
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

9.  Astragalus mongholicus ameliorates renal fibrosis by modulating HGF and TGF-beta in rats with unilateral ureteral obstruction.

Authors:  Chuan Zuo; Xi-sheng Xie; Hong-yu Qiu; Yao Deng; Da Zhu; Jun-ming Fan
Journal:  J Zhejiang Univ Sci B       Date:  2009-05       Impact factor: 3.066

10.  Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuria.

Authors:  Bernt Johan von Scholten; Henrik Reinhard; Tine W Hansen; Jens Oellgaard; Hans-Henrik Parving; Peter K Jacobsen; Peter Rossing
Journal:  Diabetologia       Date:  2016-03-31       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.